💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. The Company operates in a single segment, which primarily relates to the manufacturing…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A decent, stagnant business, reasonably priced.
Meghmani Finechem is scored on the general / industrial framework. It keeps a healthy 13.1% of every rupee of sales as net profit. Those profits are backed by real cash — operating cash flow runs 1.31× reported profit. Free cash flow is worth about 2.0% of its market value.
Over the last 3 years revenue compounded at 5%/yr and profit at -2%/yr. Book value itself has compounded 28%/yr — the hallmark of a genuine compounder. Return on equity is a healthy 12.1%. In the latest quarter profit grew 23% versus the prior quarter.
At 12× earnings, the stock sits at the 24th percentile of its own 3.6-year range — the cheap end of where it has historically traded. Today's price asks for only ~4%/yr growth over a decade — undemanding expectations. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 13.88 | 2.98 | worse |
| P/B | 1.67 | 2.69 | better |
| EV/EBITDA | 7.7 | 10.45 | better |
| ROE | 12.05 | — | — |
| ROCE | 14.61 | 69.92 | worse |
| ROA | 7.95 | — | — |
| Quick Ratio | 0.67 | 2.26 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Pidilite Industries | 59.1 | 14.3 | 23.9% |
| SRF | 32.3 | 4.8 | 14.9% |
| Linde India | 118.3 | 13.3 | 11.3% |
5% CAGR — growing but slowly. Growth is decelerating — latest year grew slower than the year before.
Revenue is outpacing profit (5% vs -2%) — costs are rising faster than the top line.
Operating margin has compressed from 24% to 13% — costs or competition are eating into profitability. Interest or tax burden is shrinking — more of the operating profit is reaching the bottom line.
ROE at 15% — a respectable return on shareholder capital. Capital efficiency declining — ROE down 18pp.
EPS dropped in the latest year despite possible profit changes — dilution or a profit dip could be at play. -3% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Cash conversion at 1.3× PAT — earnings are well-backed by cash; strong accrual quality. Heavy investing spend every year, but operations generate enough to cover it — the business self-funds its growth.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue broadly flat QoQ — stable but not accelerating. Run-rate stepping up — recent quarters average 21% above earlier ones.
Profit jumped 23% QoQ — check if this is operating leverage or a one-off item. Quarterly net margins are expanding (9% → 14%) — profitability per rupee of revenue is improving.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoters hold 68.8% — heavily owner-operated with strong skin in the game.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.